Kazia - Rasio nilai perusahaan marang dodolan KZIA

Simbol resmi perusahaan Kazia Therapeutics Ltd (KZIA)

Demand for neuro-oncology solutions remains independent of economic cycles, as brain therapy is critically important. Kazia Therapeutics (KZIA) is developing breakthrough small molecules for precision cancer treatment. This EV/Sales multiple chart helps identify speculative overvaluation of the business, with the current level standing at 368000.00. However, the R&D stage limits scaling, leading to linear growth in clinical trial costs.

Kazia Therapeutics Limited (KZIA): Nilai perusahaan marang pendapatan saka 23.11.2025 nganti 20.11.2026

Kazia Therapeutics Limited - rincian analitis lan metrik utama (KZIA)

- data saldo dhuwit lan arus kas:
Pambiji fundamental perusahaan:KZIA, Kazia
Produk sing diprodhuksi kaziatherapeutics.com

A technological barrier in the form of a patent for a glioblastoma drug determines the fundamental stability of Kazia Therapeutics (KZIA). By analyzing the EV/Sales multiple, an investor assesses the total enterprise value relative to revenue excluding debt, which allows for the determination of overpayment for future sales and the comparison of market capitalization with the company's actual financial resources under constrained budget conditions.

Analisis pesaing

Multiplikator nilai perusahaan marang pendapatan Incyte Corporation|HCM (HUTCHMED Corp) - Nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang dodolan Nuvation Pharma NUVB|Nilai perusahaan marang pendapatan DAWN|Multiplikator nilai perusahaan marang pendapatan Monopar Therapeutics MNPR|Nilai perusahaan marang pendapatan INBX (Inhibrx Biosciences)|IMAB (I-Mab Inc.) - Nilai bisnis marang pendapatan|Fennec Pharmaceuticals - Nilai perusahaan marang pendapatan|Koefisien nilai perusahaan marang pendapatan HRTX (Heron Therapeutics Inc)|Nuvectis - Multiplikator EV/Sales|Nilai bisnis marang pendapatan CHRS (Coherus BioSciences Inc.)|CRBP: Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan Cardiff Oncology Corp (CRDF)|Rasio nilai perusahaan marang pendapatan BeyondSpring|BCAB: Nilai bisnis marang pendapatan|Multiplikator EV/Sales LIXT|Multiplikator EV/Sales Citius Pharmaceuticals Inc. (CTXR)|Rasio nilai perusahaan marang pendapatan Cellectar CLRB|BLRX (BioLineRx) - Nilai perusahaan marang volume dodolan|CANF: Nilai perusahaan marang pendapatan|Multiplikator nilai perusahaan marang pendapatan aprea.com|Silexion Therapeutics Corp (SLXN) - Rasio nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan NCNA|CMRX (Chimerix, Inc.) - Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan Cyclacel Pharmaceuticals CYCC|G1 Therapeutics Inc. (GTHX) - Nilai bisnis marang pendapatan|KRON - Multiplikator nilai perusahaan marang pendapatan|Kintara Therapeutics, Inc. - Nilai perusahaan marang pendapatan|Koefisien nilai perusahaan marang pendapatan ONCT (Oncternal)|Portage Biotech Corp - Multiplikator EV/Sales